Position
Parallel Advisors, LLC in Viking Therapeutics, Inc.
Back to the book · All holders of VKTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$27.9K$35.18 → $32.54
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 10.6K | $372K | — | — | — | 0.0% |
| Q1 2026 | 14K | $456.2K | $32.54 | −$27.9K | $112.2K | 0.0% |